CBT for older adults with common mental disorders

Efficacy of transdiagnostic cognitive behavioural intervention in older adults with common mental disorders and its impact on sleep and metabolic outcomes: A randomized controlled trial. - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064480

Enrollment

120

Registered

2024-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F30-F39- Mood [affective] disorders Health Condition 2: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders

Interventions

Intervention1: Cognitive Behaviour therapy: Intervention will be a transdiagnostic cognitive behaviour therapy, designed to address shared symptom presentations and underlying mechanisms that inclu

Eligibility

Inclusion criteria

Inclusion criteria: Adults over age 55 years, 2. All genders Meeting criteria for common mental disorders as per DSM V (excluding OCD and OCRDs). 4. PHQ-9 scores 5-19 and GAD-7 scores 5-14 (mild-moderate severity). 5. Adequate or corrected hearing and vision. 6. Intact capacity to consent 7. Stabilized on medication for depression and anxiety for at least 4 weeks and consenting to keep the dose constant (unless there is worsening).

Exclusion criteria

Exclusion criteria: 1. Suicidal risk (as determined by SCID-CV screening questions on suicidality), severe major depression, agitation, psychosis, bipolar disorder- currently symptomatic, current substance dependence (other than tobacco); obsessive-compulsive disorder. 2. Significant cognitive impairments that interfere with participation in the study and/or any medical/neurological complications/disorders that may interfere with participation in the therapy. Older adults who are unable to provide consent. 3. Clinically assessed intellectual or other disability that may compromise the ability to consent and participate in CBT. 4. Having received CBT of at least 10 sessions in the last 6 months. 5. On benzodiazepines

Design outcomes

Primary

Measure	Time frame
Scores on anxiety and depression (GAD-7 and HAM A; PHQ 9; HAM-D)Timepoint: Baseline, post and 3 months	—

Secondary

Measure	Time frame
Repetitive negative thinking, sleep quality, activities of daily living, Hb1AC and lipidsTimepoint: Baseline, post and follow up	—

Countries

India

Contacts

Public ContactPaulomi M Sudhir

National Institute of Mental Health and Neurosciences

paulomi@nimhans.ac.in8026995184

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026